Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Jun-24 5:20 PM View:  | Leamon Christopher P Chief Scientific Officer | Fusion Pharmaceuticals Inc. (FUSN) | 04-Jun-24 | Disposition | 11,957 | -- | -- | (100%) 11.96K to 0 | |
| 04-Jun-24 5:31 PM View: | Gannon Steven Director | Fusion Pharmaceuticals Inc. (FUSN) | 04-Jun-24 | Disposition | 56,400 | -- | -- | (100%) 56.4K to 0 | |
| 04-Jun-24 5:27 PM View: | Rawat Mohit President & CBO | Fusion Pharmaceuticals Inc. (FUSN) | 04-Jun-24 | Disposition | 21,699 | -- | -- | (100%) 21.7K to 0 | |
| 04-Jun-24 5:21 PM View: | Burak Eric Chief Technology Officer | Fusion Pharmaceuticals Inc. (FUSN) | 04-Jun-24 | Disposition | 38,490 | -- | -- | (100%) 38.49K to 0 | |
| 04-Jun-24 5:31 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 04-Jun-24 | Disposition | 318,147 | -- | -- | (100%) 318.15K to 0 | |
| 04-Jun-24 5:26 PM View: | Crowley John J Chief Financial Officer | Fusion Pharmaceuticals Inc. (FUSN) | 04-Jun-24 | Disposition | 10,410 | -- | -- | (100%) 10.41K to 0 | |
| 05-Jan-24 8:54 AM View: | Leamon Christopher P Chief Scientific Officer | Fusion Pharmaceuticals Inc. (FUSN) | 31-Aug-23 | Grant | 11,957 | -- | -- | 100% 0 to 11.96K | |
| 05-Jan-24 8:49 AM View: | Rawat Mohit President & CBO | Fusion Pharmaceuticals Inc. (FUSN) | 31-Aug-23 | Grant | 12,843 | -- | -- | 100% 0 to 12.84K | |
| 14-Nov-22 8:31 AM View: | Khuong Chau Quang Director | Fusion Pharmaceuticals Inc. (FUSN) | 11-Nov-22 | Grant | 42,093 | $2.38 | $100,181.00 | 100% 0 to 42.09K | |
| 11-Aug-22 4:19 PM View: | Gannon Steven Director | Fusion Pharmaceuticals Inc. (FUSN) | 11-Aug-22 | Private Purchase | 44,400 | $2.03 | $90,132.00 | 370% 12.0K to 56.4K | |
| 27-Apr-22 4:34 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 27-Apr-22 | Sale (Planned) | 4,511 | $6.03 | $27,201.30 | (1%) 322.66K to 318.15K | |
| 27-Apr-22 4:34 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 26-Apr-22 | Sale (Planned) | 2,147 | $6.07 | $13,032.30 | (< 1%) 324.81K to 322.66K | |
| 27-Apr-22 4:34 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 25-Apr-22 | Private Sale (Planned) | 2,036 | $6.03 | $12,277.10 | (< 1%) 326.84K to 324.81K | |
| 22-Apr-22 8:04 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 21-Apr-22 | Sale (Planned) | 922 | $6.01 | $5,541.22 | (< 1%) 327.76K to 326.84K | |
| 22-Apr-22 8:04 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 20-Apr-22 | Private Sale (Planned) | 367 | $6.02 | $2,209.34 | (< 1%) 328.13K to 327.76K | |
| 13-Apr-22 6:10 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 13-Apr-22 | Sale (Planned) | 11,994 | $6.41 | $76,881.50 | (4%) 340.12K to 328.13K | |
| 13-Apr-22 6:10 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 12-Apr-22 | Sale (Planned) | 18,255 | $7.10 | $129,610.00 | (5%) 358.38K to 340.12K | |
| 13-Apr-22 6:10 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 11-Apr-22 | Private Sale (Planned) | 2,600 | $7.37 | $19,162.00 | (< 1%) 360.98K to 358.38K | |
| 08-Apr-22 4:21 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 08-Apr-22 | Sale (Planned) | 826 | $7.52 | $6,211.52 | (< 1%) 361.81K to 360.98K | |
| 08-Apr-22 4:21 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 07-Apr-22 | Sale (Planned) | 1,255 | $7.56 | $9,487.80 | (< 1%) 363.06K to 361.81K | |
| 08-Apr-22 4:21 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 06-Apr-22 | Private Sale (Planned) | 100 | $7.58 | $758.00 | (< 1%) 363.16K to 363.06K | |
| 05-Apr-22 5:01 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 05-Apr-22 | Sale (Planned) | 2,100 | $7.67 | $16,107.00 | (< 1%) 365.26K to 363.16K | |
| 05-Apr-22 5:01 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 04-Apr-22 | Sale (Planned) | 700 | $7.81 | $5,467.00 | (< 1%) 365.96K to 365.26K | |
| 05-Apr-22 5:01 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 01-Apr-22 | Private Sale (Planned) | 1,000 | $7.75 | $7,750.00 | (< 1%) 366.96K to 365.96K | |
| 01-Apr-22 5:36 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 30-Mar-22 | Private Sale (Planned) | 300 | $7.52 | $2,256.00 | (< 1%) 367.26K to 366.96K | |
| 29-Mar-22 4:29 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 29-Mar-22 | Sale (Planned) | 200 | $7.52 | $1,504.00 | (< 1%) 367.46K to 367.26K | |
| 29-Mar-22 4:29 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 28-Mar-22 | Sale (Planned) | 9,600 | $7.55 | $72,480.00 | (3%) 377.06K to 367.46K | |
| 29-Mar-22 4:29 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 25-Mar-22 | Private Sale (Planned) | 500 | $7.42 | $3,710.00 | (< 1%) 377.56K to 377.06K | |
| 24-Mar-22 5:32 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 23-Mar-22 | Sale (Planned) | 100 | $7.50 | $750.00 | (< 1%) 378.36K to 378.26K | |
| 24-Mar-22 5:32 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 22-Mar-22 | Sale (Planned) | 4,000 | $7.53 | $30,120.00 | (1%) 382.36K to 378.36K | |
| 21-Mar-22 5:47 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 21-Mar-22 | Sale (Planned) | 1,500 | $7.47 | $11,205.00 | (< 1%) 383.86K to 382.36K | |
| 24-Mar-22 5:32 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 21-Mar-22 | Private Sale (Planned) | 700 | $7.46 | $5,222.00 | (< 1%) 378.26K to 377.56K | |
| 21-Mar-22 5:47 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 18-Mar-22 | Sale (Planned) | 1,204 | $7.61 | $9,162.44 | (< 1%) 385.06K to 383.86K | |
| 21-Mar-22 5:47 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 17-Mar-22 | Private Sale (Planned) | 900 | $7.51 | $6,759.00 | (< 1%) 385.96K to 385.06K | |
| 16-Mar-22 4:29 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 16-Mar-22 | Sale (Planned) | 100 | $6.99 | $699.00 | (< 1%) 386.06K to 385.96K | |
| 16-Mar-22 4:29 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 15-Mar-22 | Sale (Planned) | 100 | $7.12 | $712.00 | (< 1%) 386.16K to 386.06K | |
| 16-Mar-22 4:29 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 14-Mar-22 | Private Sale (Planned) | 1,300 | $6.96 | $9,048.00 | (< 1%) 387.46K to 386.16K | |
| 14-Mar-22 4:18 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 11-Mar-22 | Sale (Planned) | 100 | $7.13 | $713.00 | (< 1%) 387.56K to 387.46K | |
| 14-Mar-22 4:18 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 10-Mar-22 | Sale (Planned) | 1,900 | $7.06 | $13,414.00 | (< 1%) 389.46K to 387.56K | |
| 14-Mar-22 4:18 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 09-Mar-22 | Private Sale (Planned) | 822 | $6.94 | $5,704.68 | (< 1%) 390.29K to 389.46K | |
| 08-Mar-22 4:59 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 08-Mar-22 | Sale (Planned) | 3,004 | $6.92 | $20,787.70 | (< 1%) 393.29K to 390.29K | |
| 08-Mar-22 4:59 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 07-Mar-22 | Sale (Planned) | 3,100 | $6.99 | $21,669.00 | (< 1%) 396.39K to 393.29K | |
| 08-Mar-22 4:59 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 04-Mar-22 | Private Sale (Planned) | 8,400 | $7.32 | $61,488.00 | (2%) 404.79K to 396.39K | |
| 03-Mar-22 10:00 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 03-Mar-22 | Sale (Planned) | 200 | $7.28 | $1,456.00 | (< 1%) 404.99K to 404.79K | |
| 03-Mar-22 10:00 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 02-Mar-22 | Sale (Planned) | 26,546 | $7.44 | $197,502.00 | (6%) 431.54K to 404.99K | |
| 03-Mar-22 10:00 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 01-Mar-22 | Private Sale (Planned) | 847 | $7.37 | $6,242.39 | (< 1%) 432.38K to 431.54K | |
| 28-Feb-22 7:13 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 28-Feb-22 | Sale (Planned) | 3,100 | $7.40 | $22,940.00 | (< 1%) 435.48K to 432.38K | |
| 28-Feb-22 7:13 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 25-Feb-22 | Sale (Planned) | 8,152 | $7.57 | $61,710.60 | (2%) 443.63K to 435.48K | |
| 28-Feb-22 7:13 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 24-Feb-22 | Private Sale (Planned) | 2,500 | $7.41 | $18,525.00 | (< 1%) 446.13K to 443.63K | |
| 23-Feb-22 5:58 PM View: | Valliant John Chief Executive Officer Director | Fusion Pharmaceuticals Inc. (FUSN) | 23-Feb-22 | Sale (Planned) | 29,299 | $7.77 | $227,653.00 | (6%) 475.43K to 446.13K |
